Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet?
The company continues to improve its pipeline. The GLP-1 market has grabbed considerable attention in the past couple of years,
Read MoreThe company continues to improve its pipeline. The GLP-1 market has grabbed considerable attention in the past couple of years,
Read MoreThe tally favors Delta over United. When people in the U.S. think about flying, Delta Air Lines (DAL 0.74%) and
Read MoreMercadoLibre may look like the “Amazon of Latin America,” but the real story runs deeper. With fintech fueling its ecosystem,
Read MoreA professional bull got even more bullish on the company’s future. A generous price target increase by an analyst was
Read MoreThe latest data from the company’s oral weight loss drug is bullish for the stock. Novo Nordisk (NVO -1.28%) has
Read MoreYou’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley
Read MoreShares of UnitedHealth have been rallying more than 10% in the past month. The problem with trying to buy a
Read MoreRigetti advanced as shares continued higher following its Sept. 18 announcement of a $5.8 million Air Force award. Rigetti Computing
Read MoreImage source: Getty Images The Fed cut interest rates last week on Sept. 17, and CD rates may not stay
Read MoreInvestors are discovering that the company might be quite a good play on the expansion of artificial intelligence (AI). Lumen
Read MoreSubscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.